Custom Formulations and Private Label Solutions Eskag Pharma provides tailored formulations and private label solutions for businesses aiming to launch unique liposomal glutathione supplements
Unfortunately, and ironically with the latest FDA restriction: Only large well-funded companies can afford FDA trials Naturally occurring peptides are hard to patent No patent = no financial incentive No incentive = no approval No approval = no legal compounding Thats the present reality, I hope this regulatory and political standstill will resolved in the coming years
Maturational development of drug-metabolizing enzymes in dogs
The photograph above, from Vanguard Lab, shows five of the concentrated tests showing a single visible control line on each strip, which would ordinarily be interpreted as a presumptive positive result
Recycling glutathione means taking glutathione that has already been used and rebuilding it so its ready for action again
NO system dependence of atropine-induced mydriasis and L-NAME- and L-arginine-induced [PMID: 26698393] Laboratory literature summary: NO system dependence of atropine-induced mydriasis and L-NAME- and L-arginine-induced miosis: Reversal by the pentadecapeptide BPC 157